Tagged with Value added

Generics Arun Narayan of Medicines for Europe’s Value Added Medicines Group has been working to promote the benefits of value added medicines and how real-world evidence must be considered. In a recent interview with PharmaBoardroom he elaborated on what some countries are already doing to adopt Value Added Medicines and the…

Generics Arun Narayan is the Chairman of the Value Added Medicines Sector Group at Medicines for Europe, in addition to serving as Head of Global Portfolio Strategy and Head of European Business Operations at Mylan. Narayan introduces compelling reasons why payers in Europe should consider Value Added Medicines, including cost savings…

Pharma Third generation family member Laure Brenas Baudry explains how CSP has become France’s leading distributor for pharmaceuticals, and how they provide value added services to their large set of clients in over 130 countries. CSP is now the leading French distributor of pharmaceutical products. How has the company grown to…